1,3,4-Thiadiazole, 2-amino-5-methyl- → HCID 15158115, compound

HRID 466015Notes

Reaction equation

HRID 466015 reaction equation
Br[CH2:2][C:3]([C:5]1[C:6]([C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)=[N:7][N:8]2[CH:13]=[CH:12][CH:11]=[CH:10][C:9]=12)=O.[NH2:20][C:21]1[S:22][C:23]([CH3:26])=[N:24][N:25]=1>C(O)CCC>[CH3:26][C:23]1[S:22][C:21]2=[N:20][C:3]([C:5]3[C:6]([C:14]4[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=4)=[N:7][N:8]4[CH:13]=[CH:12][CH:11]=[CH:10][C:9]=34)=[CH:2][N:25]2[N:24]=1

Participants

4

Procedure

A mixture of 3-(2-bromoacetyl)-2-phenylpyrazolo[1,5-a]pyridine (1.87 g), 2-amino-5-methyl-1,3,4-thiadiazole (0.68 g) and 1-butanol (19 ml) was refluxed for 5 hours and 20 minutes. The reaction mixture was evaporated in vacuo and the residue was taken up methylene chloride (40 ml). The methylene chloride solution was washed with an aqueous solution of potassium carbonate and dried over magnesium sulfate. The solvent was removed and the residue was subjected to chromatography on silica gel (25 g) with chloroform as an eluent. The fractions containing the objective compound were combined and evaporated in vacuo to give 3-(2-methylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)-2-phenylpyrazolo[1,5-a]pyridine (1.06 g), which was recrystallized from acetone gave crystals (0.69 g).

Workup

  1. temperaturewas refluxed for 5 hours and 20 minutes
  2. customThe reaction mixture was evaporated in vacuo
  3. washThe methylene chloride solution was washed with an aqueous solution of potassium carbonate
  4. dry with materialdried over magnesium sulfate
  5. customThe solvent was removed
  6. additionThe fractions containing the objective compound
  7. customevaporated in vacuo

Sources & evidence

ORD record
ord-7d73967641bf41eba31078a1b0c1ba42
Source dataset
uspto-grants-1992_10
Patent number
US05155114

Reaction notes

Loading…